Review of management options for mantle cell lymphoma in pregnancy

References

• de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–346.
   PubMed Web of Science ®Google Scholar
• El-Messidi A, Patenaude V, Abenhaim HA. Incidence and outcomes of women with non-Hodgkin’s lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res. 2015;41(4):582–589.
   PubMed Web of Science ®Google Scholar
• Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009;84(12):830–841.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang H, Fang W, et al. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 2008;113(4):791–798.
   PubMed Web of Science ®Google Scholar
• Argatoff LH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89(6):2067–2078.
   PubMed Web of Science ®Google Scholar
• Skarbnik AP, Goy AH. Mantle cell lymphoma: state of the art. Clin Adv Hematol Oncol. 2015;13(1):44–55.
   PubMedGoogle Scholar
• Jain P, Wang ML. Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. Am J Hematol. 2022;97(5):638–656.
   PubMed Web of Science ®Google Scholar
• Michelle F, Simon R. Indolent mantle cell lymphoma. Haematologica. 2011;96(8):1086–1088.
   PubMed Web of Science ®Google Scholar
• Cheah CY, Seymour JF, Wang ML. Mantle cell lymphoma. J Clin Oncol. 2016;34(11):1256–1269.
   PubMed Web of Science ®Google Scholar
• Maddocks K. Update on mantle cell lymphoma. Blood. 2018;132(16):1647–1656.
   PubMed Web of Science ®Google Scholar
• Hoster E, Klapper W, Hermine O, et al. Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the european Mantle-Cell lymphoma network. J Clin Oncol. 2014;32(13):1338–1346.
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram K, Goyal S, Switchenko J, et al. Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival. Eur J Haematol. 2021;107(3):301–310.
   PubMed Web of Science ®Google Scholar
• Anita K, Zhitao Y, Anna A, et al. Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma. Haematologica. 2019;104(4):e163–e166.
   PubMed Web of Science ®Google Scholar
• Calzada O, Switchenko JM, Maly JJ, et al. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Leuk Lymphoma. 2018;59(12):2862–2870.
   PubMed Web of Science ®Google Scholar
• Martin P, Chadburn A, Christos P, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27(8):1209–1213.
   PubMed Web of Science ®Google Scholar
• Abrisqueta P, Scott DW, Slack GW, et al. Observation as the initial management strategy in patients with mantle cell lymphoma. Ann Oncol. 2017;28(10):2489–2495.
   PubMed Web of Science ®Google Scholar
• van Gerwen M, Maggen C, Cardonick E, International Network on Cancer, Infertility and Pregnancy, et al. Association of chemotherapy timing in pregnancy with congenital malformation. JAMA Netw Open. 2021;4(6):e2113180.
   PubMed Web of Science ®Google Scholar
• Monteagudo A, Timor-Tritsch IE. Normal sonographic development of the Central nervous system from the second trimester onwards using 2D, 3D and transvaginal sonography. Prenat Diagn. 2009;29(4):326–339.
   PubMed Web of Science ®Google Scholar
• Hermine O, Hoster E, Walewski J, European Mantle Cell Lymphoma Network, et al. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL younger): a randomised, open-label, phase 3 trial of the european mantle cell lymphoma network. Lancet. 2016;388(10044):565–575.
   PubMed Web of Science ®Google Scholar
• Pola R, Pokorná E, Vočková P, et al. Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma. Acta Biomater. 2021;119:349–359.
   PubMed Web of Science ®Google Scholar
• Ratnasingam S, Casan J, Shortt J, et al. Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma. Sci Rep. 2019;99(1):13544.
   PubMedGoogle Scholar
• Eskelund CW, Dahl C, Hansen JW, et al. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 2017;130(17):1903–1910.
   PubMed Web of Science ®Google Scholar
• Merryman RW, Edwin N, Redd R, et al. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma. Blood Adv. 2020;4(5):858–867.
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Thieblemont C, Oberic L, LYSA Group, et al. Rituximab after autologous Stem-Cell transplantation in Mantle-Cell lymphoma. N Engl J Med. 2017;377(13):1250–1260.
   PubMed Web of Science ®Google Scholar
• Chihara D, Cheah CY, Westin JR, et al. Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD anderson cancer center. Br J Haematol. 2016;172(1):80–88.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283–291.
   PubMed Web of Science ®Google Scholar
• Raich PC, Curet LB. Treatment of acute leukemia during pregnancy. Cancer. 1975;36(3):861–862.
   PubMed Web of Science ®Google Scholar
• Pawliger DF, McLean FW, Noyes WD. Normal fetus after cytosine arabinoside therapy. Ann Intern Med. 1971;74(6):1012.
   PubMed Web of Science ®Google Scholar
• Das G, Damotte V, Gelfand JM, et al. Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e453.
   PubMed Web of Science ®Google Scholar
• Lishner M, Avivi I, Apperley JF, et al. Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol. 2016; 1034(5):501–508.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499–1506.
   PubMed Web of Science ®Google Scholar
• Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol. 2004;72(4):292–295.
   PubMed Web of Science ®Google Scholar
• Burnette BL, Jentoft MA, Porrata LF, et al. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. J Clin Oncol. 2014;32(7):e14–e17.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Ahn KH, Hong SC, et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth. Obstet Gynecol Sci. 2014;57(6):526–529.
   PubMedGoogle Scholar
• Odelia A, Erel J, Chava P, et al. Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire. Int J Clin Oncol. 2017;22(1):190–199.
   PubMed Web of Science ®Google Scholar
• Henderson CE, Elia G, Garfinkel D, et al. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol. 1993;49(1):92–94.
   PubMed Web of Science ®Google Scholar
• Marnitz S, Schmittel A, Bolbrinker J, et al. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum. Fertil Steril. 2009;92(5):1748.e1–4.
   PubMed Web of Science ®Google Scholar
• Geijteman ECT, Wensveen CWM, Duvekot JJ, et al. A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014;124(2 Pt 2 Suppl 1):454–456.
   PubMed Web of Science ®Google Scholar
• TREANDA® (bendamustine hydrochloride) for Injection, for intravenous infusion. 2008.
   Google Scholar
• Parmar S, Patel K, Pinilla-Ibarz J. Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia. P T. 2014;39(7):483–519.
   PubMedGoogle Scholar
• Luttwak E, Gurevich-Shapiro A, Azem F, et al. Novel agents for the treatment of lymphomas during pregnancy: a comprehensive literature review. Blood Rev. 2021;49:100831.
   PubMed Web of Science ®Google Scholar
• Horowitz NA, Benyamini N, Wohlfart K, et al. Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. Lancet Oncol. 2013;14(7):e275–e282.
   PubMed Web of Science ®Google Scholar
• Meguerian-Bedoyan Z, Lamant L, Hopfner C, et al. Anaplastic large cell lymphoma of maternal origin involving the placenta: case report and literature survey. Am J Surg Pathol. 1997;21(10):1236–1241.
   PubMed Web of Science ®Google Scholar
• Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. In: Surbone A, Peccatori F, Pavlidis N, editors. Cancer and pregnancy. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 183–194.
   Google Scholar
• Gnecco C, Carlan SJ, McWhorter J, et al. Burkitt’s lymphoma with placental invasion diagnosed at cesarean delivery: a case report. J Med Case Rep. 2018;12(1):30.
   PubMedGoogle Scholar
• Sehmi R, Angelopoulos L. Non-Hodgkin’s lymphoma in pregnancy. J Obstetr Gynaecol. 2013;33(1):88–88.
   Web of Science ®Google Scholar
• Avilés A, Díaz-Maqueo J, Torras V, et al. Non-Hodgkin’s lymphomas and pregnancy: presentation of 16 cases. Gynecol Oncol. 1990;37(3):335–337.
   PubMed Web of Science ®Google Scholar
• Silva PT, de Almeida HM, Príncipe F, et al. Non-Hodgkin lymphoma during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1998;77(2):249–251.
   PubMed Web of Science ®Google Scholar